ArticleJournal of ovarian research2021

MiR-149-3p promotes the cisplatin resistance and EMT in ovarian cancer through downregulating TIMP2 and CDKN1A.

Jin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.